# PFIZER INC stock analysis

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret br

## Market evidence and data freshness

The public preview recorded PFIZER INC at 30.39 USD on 2026-11-05T19:10:45.000Z and marked the quote as delayed. This observation is not a trading signal.
Available price history spans 2021-11-08 through 2026-11-04 across 1240 observations; the listed source is CommonQuant Parquet archive backed by Yahoo Finance delayed data. The history end date differs from the latest quote date.

## What should I review before buying PFIZER INC stock?

Compare valuation with reported financial performance, inspect the price history, and weigh the evidence for and against the investment case. Review the risks and assumptions before making your own decision.

## Inside the full report

- Valuation
- Growth
- Financial health
- Ownership
- Research

Sign in to open the full analysis. Paid plans use included reports first, then your weekly usage limit. Access lasts 72 hours, including revisits.

[Read the report](https://commonquant.ai/markets/pfe)